Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Nov 14, 2024 | 13.14 | +2.90 |
Oak Valley Bancorp | OVLY | Nov 14, 2024 | 29.85 | +1.26 |
Oak Woods Acquisition | OAKU | Nov 14, 2024 | 11.35 | +0.71 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Nov 14, 2024 | 10.03 | 0.00 |
Oaktree Capital A Pref | OAK-A | Nov 14, 2024 | 23.48 | -0.21 |
Oaktree Capital Group B Pref | OAK-B | Nov 14, 2024 | 22.69 | +0.09 |
Oaktree Specialty | OCSL | Nov 14, 2024 | 16.04 | +0.38 |
Oatly ADR | OTLY | Nov 14, 2024 | 0.64 | -0.47 |
Oblong | OBLG | Nov 14, 2024 | 4.03 | -0.25 |
Occidental Petroleum | OXY | Nov 14, 2024 | 50.67 | -0.88 |
Ocean Biomedical | OCEA | Nov 14, 2024 | 0.72 | -2.70 |
Ocean Power Technologies | OPTT | Nov 14, 2024 | 0.14 | -2.41 |
Oceaneering International | OII | Nov 14, 2024 | 27.55 | -1.01 |
OceanFirst Financial | OCFC | Nov 14, 2024 | 20.46 | -1.25 |
OceanFirst Pref | OCFCP | Nov 14, 2024 | 25.15 | +0.07 |
OceanPal | OP | Nov 14, 2024 | 1.46 | -2.67 |
Ocugen | OCGN | Nov 14, 2024 | 1.00 | +4.37 |
Ocular Therapeutix | OCUL | Nov 14, 2024 | 9.92 | -6.42 |
Oculis | OCS | Nov 14, 2024 | 14.71 | -0.07 |
Ocuphire Pharma | OCUP | Nov 14, 2024 | 1.17 | 0.00 |
Oddity Tech | ODD | Nov 14, 2024 | 42.39 | -4.98 |
Odyssey Marine Exploration | OMEX | Nov 14, 2024 | 0.41 | -6.52 |
Offerpad Solutions A | OPAD | Nov 14, 2024 | 3.73 | -12.03 |
Office Properties | OPI | Nov 14, 2024 | 1.25 | -4.58 |
OFG Bancorp | OFG | Nov 14, 2024 | 44.10 | -1.08 |
OFS Capital | OFS | Nov 14, 2024 | 8.02 | -0.25 |
OFS Credit | OCCI | Nov 14, 2024 | 7.03 | -1.40 |
OFS Credit C Pref | OCCIO | Nov 14, 2024 | 24.80 | -0.08 |
OFS Credit Company Pref F | OCCIM | Nov 14, 2024 | 25.09 | 0.00 |
OFS Credit E Pref | OCCIN | Nov 14, 2024 | 23.84 | +0.57 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.